Danielle Bianchi
daaninthelab.bsky.social
Danielle Bianchi
@daaninthelab.bsky.social
PhD student in the Brummelkamp lab at the Netherlands Cancer Institute.
Passionate about science and sarcasm. 🏳️‍🌈
1) Zincore recognises the highly conserved ZNF fold, explaining its broad ZNF recognition, and 2) Zincore locks the ZNF onto DNA, stabilizing promoter binding. Revealing an entirely new mode of how ZNFs activate transcription. 8/11
July 4, 2025 at 11:05 AM
CryoEM analysis of the Zincore bound to ZFP91 onto the DNA revealed a striking complex: instead of recognising an effector domain, Zincore binds to multiple DNA-bound ZNF domains directly, which revealed two peculiarities: 7/11 @rborza.bsky.social @tassosperrakis.bsky.social
July 4, 2025 at 11:04 AM
Additionally, in vitro binding experiments demonstrated direct binding of Zincore to ZNFs on DNA. This depended on SEPHS1 Arg371, a residue which is mutated in patients with a neurodevelopment syndrome, and turned out to be critical for transcriptional activation. 6/11
July 4, 2025 at 11:03 AM
Additional searches revealed different transcription factors to bring Zincore to chromatin: coincidentally all zinc finger transcription factors? 5/11
July 4, 2025 at 11:02 AM
Using haploid genetics in this reporter cell line identified ZFP91, a zinc finger transcription factor, as Zincore partner. ChIP-seq showed Zincore is directly involved in gene expression via recruitment to chromatin by ZFP91, though this explains only a fraction of Zincore promoter binding. 4/11
July 4, 2025 at 11:01 AM
As a PhD student, this was challenging. I worked on an uncharacterized protein complex, yet had no idea how it worked. RNAseq showed many genes were activated by QRICH1 and SEPHS1, but how? This gave us options! We made a reporter in one of Zincore's activated genes: GHDC. 3/11
July 4, 2025 at 11:01 AM
From analysing haploid genetic screens carried out by our group for different phenotypes we found that QRICH1 and SEPHS1 affect phenotypes similarly. They form a complex that we name Zincore. 2/11
July 4, 2025 at 11:00 AM